HIV Emerging Trends in Prevention & Treatment- Florida Board Approved- Pharmacy Technician

  Price  $10.00

  Credits  2

Clear


Format
Four decades after the first case of acquired immunodeficiency syndrome (AIDS) was reported, 38 million people are living with HIV worldwide.Over the last two decades, significant progress has been made in battling the disease. Since peaking in 1997, the number of new cases has decreased 40% worldwide and since 2004, AIDS-related deaths have declined more than 56%.In the US, just over 1 million people are living with HIV and new infections declined 11% between 2010 and 2017. The number of people living with HIV has increased since the late 1990s due to the availability of potent and better tolerated antiretrovirals (ARVs) that prolong life. People in the 50 to 54 year old age group account for the largest percentage of those living with HIV in the US.Individuals with HIV now have a similar life expectancy as the general population.However, complete viral suppression with antiretroviral therapy (ART) does not fully restore health. Deaths due to non-AIDS related complications range from 18.5% in sub-Saharan countries to 53% in high-income countries. These include cardiovascular,kidney, and liver diseases, as well as various types of cancer and neurologic disorders often linked with aging. Metabolic complications including dyslipidemia and type 2 diabetes can also occur.“Premature aging” of people with HIV is believed to result from persistent viral inflammation rather than toxicity from ARV therapy. This issue reviews recommended ARVs and focuses on the initial management of HIV in treatment-naïve adults, according to guidelines provided by the Department of Health and Human Services (DHHS). In addition, recommendations for ART in pregnancy are summarized and an update is included on the use of ARVs for PrEP and post-exposure prophylaxis (PEP), according to guidelines provided by the CDC.
$10.00

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Tech Drug Therapy

Author
Elias Chahine
PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  • List the antiretroviral (ARV) regimens recommended for HIV pre- and post-exposure prophylaxis, and the currently recommended initial treatments for newly HIV-infected persons. 
  • Name at least 3 single tablet regimens (STRs) and the antiviral drugs each contains. For each STR, explain how it should be taken in relation to meals. Define "optimizing ART."
  • For the ARV classes integrase strand transfer inhibitors (INSTIs) and nucleos(t)ide reverse transcriptase inhibitors (NRTIs):
    a. List the brand and generic names, and abbreviations for the antivirals in each class.
    b. Describe common and serious side effects and drug interactions.

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    20-876748
  • Universal Activity Number:
    Pharmacy Technician : 0798-0000-21-194-H02-T
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.